40% Obesity Prevalence, $170B in Costs: The Numbers Every Nutrition Executive Needs to See

Understanding the Epidemiological Shift Driving the Next Decade of Consumer Health Demand

The $100B Weight-Loss Drug Boom Has a Blind Spot — Are You Positioned for It?

Muscle Loss, Regain After Discontinuation, and GI Side Effects Are Driving Demand for Complementary Nutritional Solutions

Beyond GLP-1s and Surgery: The Case for Targeting the Gut Microbiome

Emerging Research Reveals How Dysbiosis Drives Obesity — and Why Probiotic Intervention Could Be the Missing Link

1 2 3